Institute for Neurodegenerative Disease
Mass General Institute for Neurodegenerative Disease (MIND) is committed to finding treatments to improve the lives of patients with neurodegenerative disorders like ALS, Alzheimer's disease, Huntington's disease and Parkinson's disease.
At MIND, we are committed to finding treatments and cures to improve the lives of patients with neurodegenerative disorders
Diseases We Research
MIND studies neurodegenerative disorders, most importantly Parkinson's, Huntington's, Alzheimer's and ALS
Patients pay a key part in clinical trials and studies that develop new treatments for neurodegenerative disorders
We welcome collaborators and partners from academic and industry research and clinical care
Your contributions help drive discovery and propel findings from the laboratory bench into the clinic.